KCAS Bio is excited to announce our attendance at the Applied Pharmaceutical Analysis (APA) 2024 conference, taking place from October 7-9 at Bristol Myers Squibb in Cambridge, MA. This event gathers experts from across the pharmaceutical industry to discuss the latest advancements in bioanalysis, drug development, and regulatory practices.
Exploring Cutting-Edge Workshops
The APA 2024 conference offers a series of in-depth workshops, including:
- Regulated Bioanalysis: Focusing on the latest regulatory audits, sampling strategies, and drug delivery innovations.
- Discovery Bioanalysis and New Technologies: Highlighting emerging analytical platforms, novel biotherapeutic development strategies, and case studies supporting new modalities.
- Mechanistic ADME: Addressing the role of non-CYP enzymes in drug-drug interactions, PK/PD challenges of new modalities, and new in vitro ADME assay approaches.
Networking and Collaboration Opportunities
APA 2024 is an excellent opportunity for professionals to network, share insights, and collaborate on innovative solutions in pharmaceutical analysis. Attendees will have access to plenary lectures from industry leaders and sessions on critical topics such as AI in drug development, bioanalytical method case studies, and advancements in predicting drug metabolism.
Meet KCAS Bio at APA 2024
We invite you to join us at APA 2024 to explore how KCAS Bio’s cutting-edge bioanalytical services can support your pharmaceutical projects. Our team of experts is eager to discuss your specific needs and demonstrate our commitment to delivering high-quality bioanalytical solutions.
Connect with Us
Don’t miss the chance to connect with KCAS Bio at APA 2024. Reach out to us to schedule a meeting during the conference and discover how we can help advance your pharmaceutical analysis projects. Contact us today to secure your spot and ensure your project benefits from the latest innovations in bioanalysis.
We look forward to seeing you in Cambridge this October!